Atzori, M.G.; Ceci, C.; Ruffini, F.; Scimeca, M.; Cicconi, R.; Mattei, M.; Lacal, P.M.; Graziani, G.
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor. Cancers 2022, 14, 5578.
https://doi.org/10.3390/cancers14225578
AMA Style
Atzori MG, Ceci C, Ruffini F, Scimeca M, Cicconi R, Mattei M, Lacal PM, Graziani G.
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor. Cancers. 2022; 14(22):5578.
https://doi.org/10.3390/cancers14225578
Chicago/Turabian Style
Atzori, Maria Grazia, Claudia Ceci, Federica Ruffini, Manuel Scimeca, Rosella Cicconi, Maurizio Mattei, Pedro Miguel Lacal, and Grazia Graziani.
2022. "The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor" Cancers 14, no. 22: 5578.
https://doi.org/10.3390/cancers14225578
APA Style
Atzori, M. G., Ceci, C., Ruffini, F., Scimeca, M., Cicconi, R., Mattei, M., Lacal, P. M., & Graziani, G.
(2022). The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor. Cancers, 14(22), 5578.
https://doi.org/10.3390/cancers14225578